| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |